Kukje Pharma (002720) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Kukje Pharma (002720) reported revenue of 175.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025175.5 billion KRW6.2 billion KRW5.7 billion KRW[source]
2024156.5 billion KRW6.7 billion KRW5.2 billion KRW[source]
2023135.4 billion KRW-2.0 billion KRW-8.4 billion KRW[source]
2022126.6 billion KRW5.3 billion KRW3.5 billion KRW[source]
2021119.7 billion KRW-1.7 billion KRW-1.6 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025180.5 billion KRW84.2 billion KRW96.2 billion KRW[source]
2024163.9 billion KRW75.6 billion KRW88.3 billion KRW[source]
2023161.6 billion KRW77.9 billion KRW83.7 billion KRW[source]
2022135.0 billion KRW62.2 billion KRW72.8 billion KRW[source]
2021138.1 billion KRW70.6 billion KRW67.5 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
20255.8 billion KRW-4.2 billion KRW344 million KRW[source]
20243.9 billion KRW-4.8 billion KRW-1.2 billion KRW[source]
20233.6 billion KRW-1.2 billion KRW2.6 billion KRW[source]
20226.5 billion KRW-1.3 billion KRW-7.5 billion KRW[source]
20219.6 billion KRW-3.4 billion KRW-2.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice